Skip to content

Clinical trials

Recruiting Neurocognitive Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Status: Recruiting Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20212
20222
20233
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Alzheimer's Disease and Related Disorders Association, Inc1
Baptist Health South Florida1
Eastern Virginia Medical School1
MapLight Therapeutics1
Mclean Hospital1
Medical University of South Carolina1
Oregon Health and Science University1
Stephanie Grasso1
Texas Tech University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders14
Alzheimer Disease9
Dementia7
Neurodegenerative Diseases7
Cognitive Dysfunction6
Brain Diseases5
Nervous System Diseases5
Central Nervous System Diseases4
Mental Disorders4
Tauopathies4

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.